3,4,5-trimethoxybenzoic acid has been researched along with Colorectal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Chen, J; Guo, J; He, Y; Jin, P; Li, Y; Liu, K; Pan, Y; Sheng, J; Su, H; Su, M; Tang, S; Tang, T; Wang, H; Wang, Q; Xiong, F | 1 |
| Ariffin, A; Chan, ZCK; Kareem, HS; Leong, KH; Noor, SM; Norazit, A | 1 |
2 other study(ies) available for 3,4,5-trimethoxybenzoic acid and Colorectal Neoplasms
| Article | Year |
|---|---|
Serum metabolite signatures in normal individuals and patients with colorectal adenoma or colorectal cancer using UPLC-MS/MS method.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Acetylglucosamine; Adenocarcinoma; Adenoma; Chenodeoxycholic Acid; Chromatography, High Pressure Liquid; Chromatography, Liquid; Colorectal Neoplasms; Cystine; Glucose; Humans; Mannose; Sarcosine; Tandem Mass Spectrometry | 2023 |
Activation of death receptor, DR5 and mitochondria-mediated apoptosis by a 3,4,5-trimethoxybenzyloxy derivative in wild-type and p53 mutant colorectal cancer cell lines.
Topics: Antineoplastic Agents; Apoptosis; Colorectal Neoplasms; Dose-Response Relationship, Drug; Gallic Acid; HCT116 Cells; HT29 Cells; Humans; Mitochondria; Mutation; Receptors, TNF-Related Apoptosis-Inducing Ligand; Structure-Activity Relationship; Tumor Suppressor Protein p53 | 2020 |